Ricerca

Pubblicazioni IRIS

• Intracellular Nanopharmacology of Trastuzumab Deruxtecan Reveals Lysosome-Centered Organelle Vulnerabilities in HER2-Positive Breast Cancer Cells
  Anno: 2026
• Theranostic Frontiers in HER2-Positive Breast Cancer: Nanomedicine Meets Morphology
  Anno: 2026
• Insights into mitochondrial dysfunction in spinal bulbar muscular atrophy through IPSC-derived skeletal muscle models
  Anno: 2025